Skip to main content
. 2023 May 10;11:1167104. doi: 10.3389/fpubh.2023.1167104

Table 4b.

Motivation, health-related quality of life, HIV treatment engagement, and HIV viral load over time (Mean [SD] or percent).

Baseline Follow-Up One Follow-Up Two
No TMQQ (n = 41) Yes TMQQ (n = 39) No TMQQ (n = 28) Yes TMQQ (n = 32) No TMQQ (n = 31) Yes TMQQ (n = 27)
Motivation (0–100)
Motivation for HIV Care 89.1 (19.7) 92.0 (12.1) 96.0 (6.05) 94.5 (8.35) 95.6 (6.83) 95.9 (9.06)
Motivation for High HIV Medication Adherence 82.0 (26.0) 83.2 (19.3) 93.9 (8.95) 92.8 (9.35) 96.0 (6.03) 94.5 (11.2)
Motivation for Undetectable Viral Load 89.2 (19.8) 88.7 (17.1) 91.8 (17.0) 91.4 (12.8) 90.3 (15.4) 95.2 (7.86)
SF-12 health-related quality of life
SF-6D health utility score 0.671 (0.188) 0.719 (0.184) 0.682 (0.196) 0.794 (0.172) 0.729 (0.203) 0.728 (0.182)
SF-12 Physical health T-score 42.2 (12.3) 45.8 (10.4) 42.8 (11.5) 47.3 (10.2) 45.8 (11.8) 46.8 (10.5)
SF-12 Mental health T-score 44.4 (14.0) 47.1 (10.6) 45.7 (12.3) 51.7 (7.77) 46.1 (12.0) 45.5 (10.1)
HIV treatment engagement
HIV Medication adherence (0–100) 62.0 (40.8) 54.6 (38.8) 71.3 (25.7) 66.8 (29.0) 74.6 (23.4) 73.4 (24.1)
HIV Medication taken in Past 4 Weeks 33 (80.5%) 29 (74.4%) 27 (96.4%) 30 (93.8%) 31 (100%) 27 (100%)
HIV viral load
log10 HIV viral load 4.01 (0.87) 3.83 (0.96) 3.35 (1.45) 3.30 (1.51) 2.84 (1.45) 3.45 (1.63)
Suppressed (viral load < 200) 0 (0%) 0 (0%) 8 (25.8%) 8 (25.8%) 11 (35.5%) 9 (31.0%)

At Follow-Up One, viral load was available for 31 participants assigned to TMQQ and 31 participants not assigned to TMQQ. At Follow-Up Two, viral load was available for 29 participants assigned to TMQQ and 31 participants not assigned to TMQQ.

Assigned to TMQQ and 31 participants not assigned to TMQQ.